14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
Von Kaenel v. Armstrong Teasdale, LLP, No. 18-2850 (8th Cir. 2019) The question whether an individu...
Read More >
The U.S. Equal Employment Opportunity Commission (EEOC) has sued Yale New Haven Hospital based on th...
Read More >
In terms of value, the technology and healthcare sectors—separately and, sometimes, in tandem—have...
Read More >
Our three-part series on government contractor M&A transactions provides an overview of key regulato...
Read More >
On February 4, 2021, the Federal Trade Commission (FTC) announced the temporary suspension of grants...
Read More >
Westchester County employers will soon need to provide paid safe time leave to employees who are the...
Read More >